The European Digital Technology and Software Conference is designed to empower regulatory professionals and their stakeholders need on artificial intelligence, software, digital technology, and more across all healthcare product sectors. Daniel Rabbie (Partner) will be attending to copresent on the adoption of AI in regulatory affairs.

Please get in touch with Daniel or the PrimeRA Pharma Partners team if you would like to arrange a meeting.

Session Title: "Optimizing Human-AI Collaboration in Regulatory Medical Writing: Make AI work for you"
Date: Friday October 31, 2025
Time: 1:45 PM - 2:45 PM
Presenter: Josh Kim – CEO – Artos Inc.
Presenter: Daniel Rabbie – Partner – PrimeRA Pharma Partners LLP

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. We are excited that PrimeRA Pharma Partners will be part of this event taking place in Phoenix, Arizona where our Managing Partner, Sean Russell will be in attendance. Please get in touch if you are planning to attend and would like to meet to discuss your programme.

Daniel Rabbie, Partner will be leading The Organisation for Professionals in Regulatory Affairs (TOPRA) Masterclass in Cell, Tissue & Gene Therapies. This 3-day course is designed for regulatory affairs professionals to develop their understanding of all aspects of the regulation of advanced therapy medicinal products, providing real-world examples from a variety of industry experts.

We’re excited to be attending Advanced Therapies Europe 2025 in Barcelona. Get in touch with Daniel Rabbie, Partner if you would like to discuss your cell and gene therapy programme and how PrimeRA Pharma Partners could help meet your objectives.

Fireside Chat: Non-Profit/Alliance Updates

14:00-15:05 Tuesday, 10 June, 2025, Salon D

Sean Russell will join Barbara Bonamassa (Italian Medicines Agency, AIFA) and Diane Blumenthal (Dianthus Biopharma Consulting, LLC) to explore how non-profit entities are navigating the challenges of bringing ATMPs to patients in desperate need.

We’re pleased to be providing regulatory insights on this residential course aimed at those developing treatments for children and young adults with cancer.

Managing Partner, Sean Russell, will be joining other biotech and regulatory authority representatives on a panel discussion at the Alliance for Regenerative Medicine’s EU event, Meeting on the Med representing the academic and not-for-profit perspective on behalf of Fondazione Telethon.

Regulatory Convergence for ATMPs: Building Global Standards
{Salone dei Cavalieri, Section 3&4}

April 16 | 9:45am – 10:30am

Moderator:

Anne-Virginie Eggimann, Chief Regulatory Officer, Tessera Therapeutics

Speakers:

Julian Beach, Executive Director Healthcare Quality and Access, MHRA

Sol Ruiz, Ph.D., Head, Unit of Biotechnology and Advanced Therapies, Spanish Medicines Agency

Sean Russell, Head of Regulatory Affairs, Fondazione Telethon

Our Managing Partner, Sean Russell, will be joining other distinguished leaders on 3 panel discussions at Advanced Therapies 2025.